34 research outputs found
Effect of the Novel Influenza A (H1N1) Virus in the Human Immune System
BACKGROUND: The pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in the immune system of the host. METHODOLOGY/PRINCIPAL FINDINGS: Blood was sampled within the first two days of the presentation of signs of infection from 10 healthy volunteers; from 18 cases of flu-like syndrome; and from 31 cases of infection by H1N1 confirmed by reverse RT-PCR. Absolute counts of subtypes of monocytes and of lymphocytes were determined after staining with monoclonal antibodies and analysis by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from patients and stimulated with various bacterial stimuli. Concentrations of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-18, interferon (FN)-alpha and of IFN-gamma were estimated in supernatants by an enzyme immunoassay. Infection by H1N1 was accompanied by an increase of monocytes. PBMCs of patients evoked strong cytokine production after stimulation with most of bacterial stimuli. Defective cytokine responses were shown in response to stimulation with phytohemagglutin and with heat-killed Streptococcus pneumoniae. Adaptive immune responses of H1N1-infected patients were characterized by decreases of CD4-lymphocytes and of B-lymphocytes and by increase of T-regulatory lymphocytes (Tregs). CONCLUSIONS/SIGNIFICANCE: Infection by the H1N1 virus is accompanied by a characteristic impairment of the innate immune responses characterized by defective cytokine responses to S.pneumoniae. Alterations of the adaptive immune responses are predominated by increase of Tregs. These findings signify a predisposition for pneumococcal infections after infection by H1N1 influenza
Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts
Introduction: It has been proposed that individual genetic variation contributes to the course of severe infections and sepsis. Recent studies of single nucleotide polymorphisms (SNPs) within the endotoxin receptor and its signaling system showed an association with the risk of disease development. This study aims to examine the response associated with genetic variations of TLR4, the receptor for bacterial LPS, and a central intracellular signal transducer (TIRAP/Mal) on cytokine release and for susceptibility and course of severe hospital acquired infections in distinct patient populations. Methods: Three intensive care units in tertiary care university hospitals in Greece and Germany participated. 375 and 415 postoperative patients and 159 patients with ventilator associated pneumonia (VAP) were included. TLR4 and TIRAP/Mal polymorphisms in 375 general surgical patients were associated with risk of infection, clinical course and outcome. In two prospective studies, 415 patients following cardiac surgery and 159 patients with newly diagnosed VAP predominantly caused by Gram-negative bacteria were studied for cytokine levels in-vivo and after ex-vivo monocyte stimulation and clinical course. Results: Patients simultaneously carrying polymorphisms in TIRAP/Mal and TLR4 and patients homozygous for the TIRAP/Mal SNP had a significantly higher risk of severe infections after surgery (odds ratio (OR) 5.5; confidence interval (CI): 1.34 - 22.64; P = 0.02 and OR: 7.3; CI: 1.89 - 28.50; P < 0.01 respectively). Additionally we found significantly lower circulating cytokine levels in double-mutant individuals with ventilator associated pneumonia and reduced cytokine production in an ex-vivo monocyte stimulation assay, but this difference was not apparent in TIRAP/Mal-homozygous patients. In cardiac surgery patients without infection, the cytokine release profiles were not changed when comparing different genotypes. Conclusions: Carriers of mutations in sequential components of the TLR signaling system may have an increased risk for severe infections. Patients with this genotype showed a decrease in cytokine release when infected which was not apparent in patients with sterile inflammation following cardiac surgery
Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice
Inflammatory reactions activated by pattern recognition receptors (PRRs) on the membrane of innate immune cells play an important role in atherosclerosis. Whether the PRRs of the C-type lectin receptor (CLR) family including Dectin-2 may be involved in the pathogenesis of atherosclerosis remains largely unknown. Recently, the CLR-adaptor molecule caspase recruitment domain family member 9 (CARD9) has been suggested to play a role in cardiovascular pathologies as it provides the link between CLR activation and transcription of inflammatory cytokines as well as immune cell recruitment. We therefore evaluated whether hematopoietic deletion of Dectin-2 or CARD9 reduces inflammation and atherosclerosis development. Low-density lipoprotein receptor (Ldlr)- knockout mice were transplanted with bone marrow from wild-type, Dectin-2- or Card9-knockout mice and fed a Western-type diet containing 0.1% (w/w) cholesterol. After 10 weeks, lipid and inflammatory parameters were measured and atherosclerosis development was determined. Deletion of hematopoietic Dectin-2 or CARD9 did not influence plasma triglyceride and cholesterol levels. Deletion of hematopoietic Dectin-2 did not affect atherosclerotic lesion area, immune cell composition, ex vivo cytokine secretion by peritoneal cells or bone marrow derived macrophages. Unexpectedly, deletion of hematopoietic CARD9 increased atherosclerotic lesion formation and lesion severity. Deletion of hematopoietic CARD9 did also not influence circulating immune cell composition and peripheral cytokine secretion. Besides a tendency to a reduced macrophage content within these lesions, plasma MCP-1 levels decreased upon WTD feeding. Deletion of hematopoietic Dectin-2 did not influence atherosclerosis development in hyperlipidemic mice. The absence of CARD9 unexpectedly increased atherosclerotic lesion size and severity, suggesting that the presence of CARD9 may protect against initiation of atherosclerosis development
Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial
Objective:
To evaluate the long-term efficacy of etanercept for the management of
hidradenitis suppurativa.
Methods:
Analysis was based on the long-term follow-up (weeks 24-144) of 10
patients enrolled in a prospective open-label phase II study; etanercept
was initially administered subcutaneously 50 mg once weekly for 12 weeks
in 10 patients. Disease recurrence and the need to restart etanercept
were recorded.
Results:
Three patients did not report any disease recurrence. A second course of
treatment with etanercept was needed in seven patients. Favourable
responses were found in five; two patients failed treatment.
Conclusions:
The first treatment course achieved long-term disease remission in
almost one-third of patients. The remaining needed a second treatment
course but even in that case, their disease severity at restart was
significantly lower compared with baseline
Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature
Digital ischemia has been rarely associated, as a paraneoplastic
syndrome, with renal cancer. Since it can severely compromise the
patients' quality of life, early recognition is important, in order to
optimally address it with currently available treatment options, such as
tyrosine inhibitors. Digital ischemia may occur in the general
population and it can be the result of other non-cancerous diseases;
accordingly, a thorough and aggressive work-up is mandatory, together
with appropriate therapeutic steps such as tyrosine kinase inhibitors,
vasodilators, and antiaggregants. Herein, we report a 78-year-old male
patient with a history of clear-cell renal-cell cancer, who presented in
the emergency department with critical ischemia in the upper limbs
Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease
Objectives Triggering receptor expressed on myeloid cells (TREM-1) is a
promoter of cytokine production triggered by microbial components. To
investigate the significance of its soluble counterpart, sTREM-1, for
the pathogenesis of peptic ulcer disease, sTREM-1 was compared with the
proinflammatory mediators and the pathology score of gastritis.
Methods Forty patients with dyspepsia were enrolled: 20 with peptic
ulcer and 20 controls without any macroscopic abnormalities. All
patients were examined by endoscopy; gastric juice was aspirated and
biopsy specimens were collected from the antrum and corpus of the
stomach. sTREM-1 was estimated by at hand-made enzyme immunoassay.
Interleukin-8 was estimated by enzyme-linked immunosorbent assay and
lipid peroxidation, indexed by malondialdehyde, by the thiobarbituric
assay, after passage through a high-performance liquid chromatography
system.
Results The median (+/- SE) of sTREM-1 of controls and patients with
ulcer was 3.91 +/- 0.57 and 44.27 +/- 241.55 R U, respectively
(P=0.006). The median (+/- SE) of interleukin-8 of controls and patients
with ulcer was 1802.97 +/- 122.10 and 2030.66 +/- 64.44 pg/ml,
respectively (P = 0.023). sTREM-1 was positively correlated with the
density of neutrophil and mononuclear infiltration scores and the total
Sydney score (P=0.029, 0.043 and 0.041, respectively). sTREM-1 was
positively correlated with interleukin-8 (P=0.042).
Conclusions sTREM-1 might be an independent factor involving with the
peptic ulcerative inflammatory process that is positively correlated
with histopathological abnormalities of gastritis
n-6 Polyunsaturated Fatty Acids Enhance the Activities of Ceftazidime and Amikacin in Experimental Sepsis Caused by Multidrug-Resistant Pseudomonas aeruginosa
Recent in vitro and ex vivo studies disclosed an enhancement of the activity of antimicrobials on multidrug-resistant Pseudomonas aeruginosa by n-6 polyunsaturated fatty acids (PUFAS); therefore their effect was evaluated in experimental sepsis in 60 rabbits. Solutions of gamma-linolenic acid (GLA) and arachidonic acid (AA) were administered intravenously with ceftazidime and amikacin in rabbits with sepsis caused by one multidrug-resistant isolate. Therapy was started after bacterial challenge in five groups comprising 12 animals in each group: A, normal saline; B, antimicrobials; C, 99% ethanol and antimicrobials; D, GLA and antimicrobials; and E, AA and antimicrobials. Blood was sampled for the estimation of levels of endotoxins in serum (lipopolysaccharide), leukocytes, tumor necrosis factor alpha (TNF-α) and antimicrobials. Animals were sacrificed 210 min after bacterial challenge for tissue cultures. All animals had considerable endotoxemia and evolved leukopenia. The number of viable cells in blood, lung, and mesenteric lymph nodes was significantly reduced in groups D and E compared to that in other groups. Levels of antimicrobials in serum were inadequate to achieve bacterial killing due to the level of resistance. n-6 PUFAs did not influence TNF-α. It is concluded that intravenous coadministration of n-6 PUFAs and antimicrobials enhanced antimicrobial bacterial killing in experimental sepsis caused by multidrug-resistant P. aeruginosa
Hypoxemic resuscitation after hemorrhagic shock is accompanied by reduced serum levels of angiopoietin-2
Background: To investigate whether angiopoietin-2 (Ang2) and vascular
endothelial growth factor (VEGF) are implicated in the hypoxemic
resuscitation from hemorrhagic shock. Methods: Twenty rabbits were
subjected to hemorrhagic shock after blood exsanguination; resuscitation
was performed by infusion of the shed blood in ten rabbits under
normoxemic conditions (NormoxRes) and in 10 under hypoxemic conditions
(HypoxRes); four rabbits were subjected to sham operation. Serum was
drawn at serial time intervals: serum was applied for stimulation of
U937 monocytes. Results: Serum concentrations of Ang2 were higher in the
NormoxRes group compared to the HypoxRes group at 90 min (p: 0.049) and
at 120 min (p: 0.028). Serum concentrations of VEGF did not differ
between groups. Concentrations of VEGF in the supernatants of U937
stimulated with sera of all groups were below detection limit The wet to
dry. lung ratio of the HypoxRes group was significantly lower than the
NormoxRes group (p < 0.0001). Conclusions: Hypoxemic resuscitation from
hemorrhagic shock is a process accompanied by reduced serum levels of
Ang2. These findings add significantly to our understanding of that
experimental treatment strategy of resuscitation. (C) 2009 Elsevier Ltd.
All rights reserved